dPCR and qPCR Market Size and Forecasts (2020-2030)

dPCR and qPCR Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment [Quantitative PCR (qPCR) and Digital PCR (dPCR)], Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Send Enquiry

$3,185$5,985

Description

The dPCR and qPCR market size is expected to grow from US$ 8.976 billion in 2022 to US$ 18.230 billion by 2030; it is estimated to record a CAGR of 9.3% during 2022-2030.

The dPCR and qPCR market growth is attributed to the increasing incidence of genetic and infectious diseases, rising investments and funds for gene synthesis, and technological advancements in PCR technologies.

In recent years, molecular methods such as PCR have evolved as diagnostic technology. The method enables healthcare professionals to diagnose a wide range of infectious diseases accurately and is considered an indispensable research and diagnostic tool. PCR allows the generation of millions of DNA copies from one single strand of DNA. It also allows early diagnosis of disease and hence plays an essential role in disease control. PCR gives reproducible results that are comparable between different laboratories and hence are accepted worldwide. As PCR techniques are being widely accepted and utilized in emerging countries. According to the World Health Organization Report on the Establishment of PCR Laboratory in Developing Countries 2016, WHO is providing necessary technical assistance to establish PCR laboratories in all 11 member states of the WHO South East Asia countries. The laboratories will help in providing high-quality medical care. These PCR laboratories have adopted different PCR technologies such as Reverse transcriptase PCR (RT-PCR), Multiplex PCR, Real-time PCR, In-situ PCR, Digital PCR (dPCR), and others depending on their need. Due to its simple, rapid, and highly specific screening of diseases and its increasing application in clinical microbiology, virology, parasitology, biotechnology, and allied fields, the dPCR and qPCR market in developing countries is expected to experience lucrative opportunities during the forecast period.

Droplet Digital PCR (ddPCR) is a new technique for performing digital PCR. It utilizes water-oil emulsion droplet technology. A sample to be tested is fractionated into around 20,000 droplets, and then amplification of the target DNA strand is carried out in each droplet. The ddPCR then digitally measures the nucleic acid targets in the individual droplet. Thus, the technique gives high precision and absolute quantification of target DNA molecules and enables wide application in diagnosis and research. In qPCR, DNA quantification is obtained from the cycle threshold (CT). External calibrators are required, and imperfect amplification affects absolute quantitation. Droplet Digital PCR (ddPCR) directly counts the target DNA without the calibration curve. Thus, with the advent of ddPCR, scientists will be able to explore complex genetic landscapes, discover and validate new disease associations, and define a new era of molecular diagnostics. Thus, the development of ddPCR would become a major trend in the dPCR and qPCR market in the future.

Application-Based Insights

Based on application, the dPCR and qPCR market is segmented into research application, clinical application, and forensic application. In 2022, the clinical application segment held the largest share of the market and is anticipated to register the highest CAGR during 2022–2030. Molecular biology techniques have revolutionized disease diagnosis and are now a crucial part of laboratory diagnostics. The dPCR and qPCR techniques are now being used in the diagnosis of many diseases, including diabetes, infectious diseases, cancer, and others. For instance, real-time PCR technology RIDA GENE kits are developed for the diagnosis of gastrointestinal infections, hospital-acquired infections (HAI), respiratory infections, sexually transmitted infections, and other parameters. As these molecular methods allow early, sensitive, and specific diagnosis, the clinical application segment is expected to witness growth over the forecast period.

Real-time PCR technologies have been used to detect mutation in genes, which helps in the diagnosis of cancer. dPCR also enables precise detection of tumor markers in cell-free DNA (cfDNA) samples like sputum, urine, cerebrospinal fluid, plasma, and others. dPCR is more effective in detecting single-nucleotide polymorphism among the wild-type sequences. For example, dPCR is commonly used to detect mutation in epidermal growth factor receptor (EGFR), KRAS, and ESR1.

Furthermore, technological advancements are offering molecular markers for diagnosing and treating cancer. In April 2023, Thermo Fisher Scientific introduced 37 CE-IVD-marked real-time PCR assay kits for its QuantStudio Dx series of instruments to detect numerous infectious diseases.

End User-Based Insights

Based on end user, the dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. In 2022, the hospitals and diagnostic centers segment held the largest share of the market and is anticipated to register the highest CAGR during 2022–2030.

Hospitals and diagnostic centers contribute a significant market share to the dPCR and qPCR market. Hospitals are the primary centers for a patient seeking highly advanced treatment under the guidance of much-trained personnel. dPCR and qPCR offer advantages such as high sensitivity and specificity, allowing early and accurate detection of pathogens, including bacteria, viruses, and fungi.

In addition, hospitals offer advanced diagnosis and treatment options for patients to treat acute and chronic conditions, and the adoption of PCR techniques is much higher in hospitals and diagnostic centers as they provide healthcare facilities with specialized scientific equipment. Moreover, the continued expansion of healthcare infrastructure across emerging countries, the high incidences of infectious diseases, and the growing number of hospital admissions has created a need for rapid and sensitive diagnostic tools. Additionally, growing demand for early and efficient disease diagnosis and treatment, the increasing number of dPCR product launches for diagnostic applications, the advantages offered by dPCR in disease diagnosis (as compared to other PCR technologies), and growing awareness among public associated with the benefits offered by both these technologies for clinical and disease diagnosis fuel the market growth.

Furthermore, diagnostic laboratories are well-equipped with hi-tech equipment that enables easy workflow and management of various samples to be tested. For instance, Thermo Fisher Scientific, Inc. offers multiple variants of its PCR, including QuantStudio 5, QuantStudio 6 Flex, QuantStudio 7, QuantStudio 12k, QuantStudio 3D, and QuantStudio Absolute Q AutoRun dPCR Suite. Similarly, several companies, such as Bio-Rad Laboratories, Inc., Fluidigm Corporation, Eppendorf, and Agilent Technologies, Inc., offer PCR devices to hospitals and diagnostic centers based on their capacity and requirements.

Centers for Disease Control and Prevention, Medical Research Future Fund, and the World Health Organization (WHO) are among the primary and secondary sources referred to while preparing the dPCR and qPCR market report.

Summary Info

Industry:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

Reagents & Consumables Segment to Lead Global dPCR and qPCR Market During 2022–2030

According to our new research study on “dPCR and qPCR Market Forecast To 2030 – Global Analysis – by Treatment, Product, Application, and End User,” the dPCR and qPCR market is expected to grow from US$ 8.976 billion in 2022 to US$ 18.230 billion by 2030; it is estimated to record a CAGR of 9.3% from 2022–2030. Key factors driving the dPCR and qPCR market growth are the increasing incidence of genetic and infectious diseases, rising investments and funds for gene synthesis, and technological advancements in PCR technologies.

The dPCR and qPCR market, by product, is segmented into reagents & consumables, instruments, and software & services. In 2022, the reagents & consumables segment held the largest share of the market and is anticipated to register the highest CAGR in the dPCR and qPCR market during the forecast period. The reagents & consumables segment is the most promising segment of the dPCR and qPCR market and contributes to tremendous growth during the forecast period. Reagents and consumables are essential parts of the dPCR and qPCR procedures. It includes buffers, probes, enzymes, dyes, vials, kits, panels, and others. Also, there are several kits available for gene expression analysis, SNP genotyping analysis, microRNA analysis, and others. The growing demand for earlier detection of disease, widespread use of consumables and reagents, and expanding demand for PCRs for healthcare, research, and other purposes have significantly fueled the growth of the segment.

The reagents and consumables market is characterized by the presence of a large number of manufacturers such as Thermo Fisher Scientific, Kaneka Eurogentec S.A., and QIAGEN. Moreover, developments, frequent product launches, rising acceptance of technology innovations, and increasing availability of the products are among the significant factors contributing to the growth of the segment. For instance, in July 2023, QIAGEN launched the CGT Viral Vector Lysis kit for the biopharmaceutical industry, expanding its range of dPCR kits and services. Therefore, these factors fuel the reagents & consumables segment of the dPCR and qPCR market to grow significantly in the near future.

Abbott Laboratories, Thermo Fisher Scientific Inc., Takara Bio Inc., Qiagen NV, Standard Biotools Inc., Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-la Roche Ltd, Bio-rad Laboratories Inc, Agilent Technologies Inc, and Genome Diagnostics Pvt Ltd are among the leading companies operating in the dPCR and qPCR market.

dPCR and qPCR Market, by Region, 2022(%)

Source: the research team Analysis

Based on treatment, the dPCR and qPCR market is bifurcated into quantitative PCR and digital PCR. In terms of product, the dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. Based on application, the dPCR and qPCR market is segmented into research application, clinical application, and forensic application. In terms of end user, the dPCR and qPCR market is segmented into hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, forensic laboratories, and clinical research organizations. By geography, the dPCR and qPCR market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the dPCR and qPCR market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the global dPCR and qPCR market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth global dPCR and qPCR market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interests with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. dPCR and qPCR Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. dPCR and qPCR Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Genetic and Infectious Diseases
5.1.2 Rising Investments and Funds for Gene Synthesis
5.1.3 Technological Advancements in PCR Technologies
5.2 Market Restraints
5.2.1 High Costs of PCR Systems
5.2.2 Technical Limitations Associated with qPCR
5.3 Market Opportunities
5.3.1 Growing Adoption of PCR Methods in Emerging Countries
5.4 Future Trends
5.4.1 Development of Droplet Digital PCR
5.5 Impact Analysis:
6. dPCR and qPCR Market – Global Market Analysis
6.1 dPCR and qPCR Market Revenue (US$ Mn), 2022 – 2030
7. Global dPCR and qPCR Market – Revenue and Forecast to 2030 – by Treatment
7.1 Overview
7.2 dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
7.3 Quantitative PCR
7.3.1 Overview
7.3.2 Quantitative PCR: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Digital PCR
7.4.1 Overview
7.4.2 Digital PCR: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8. Global dPCR and qPCR Market – Revenue and Forecast to 2030 – by Product
8.1 Overview
8.2 dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
8.3 Reagents & Consumables
8.3.1 Overview
8.3.2 Reagents & Consumables: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Instruments
8.4.1 Overview
8.4.2 Instruments: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Software & Services
8.5.1 Overview
8.5.2 Software & Services: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9. Global dPCR and qPCR Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
9.3 Research Application
9.3.1 Overview
9.3.2 Research Application: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Clinical Application
9.4.1 Overview
9.4.2 Clinical Application: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.1 dPCR and qPCR Market, by Clinical Application, 2020–2030 (US$ Million)
9.5 Forensic Application
9.5.1 Overview
9.5.2 Forensic Application: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10. Global dPCR and qPCR Market – Revenue and Forecast to 2030 – by End-User
10.1 Overview
10.2 dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
10.3 Hospitals and Diagnostic Centers
10.3.1 Overview
10.3.2 Hospitals and Diagnostic Centers: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical and Biotechnology Companies
10.4.1 Overview
10.4.2 Pharmaceutical and Biotechnology Companies: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research Laboratories and Academic Institutes
10.5.1 Overview
10.5.2 Research Laboratories and Academic Institutes: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Forensic Laboratories
10.6.1 Overview
10.6.2 Forensic Laboratories: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.7 Clinical Research Organizations
10.7.1 Overview
10.7.2 Clinical Research Organizations: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
11. dPCR and qPCR Market – Geographical Analysis
11.1 North America dPCR and qPCR Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3 North America: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.1.4 North America: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.1.5 North America: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.1.5.1 North America: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.6 North America: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.1.6.1 North America dPCR and qPCR Market, by Country
11.1.6.2 US
11.1.6.2.1 US dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.6.2.2 US: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.1.6.2.3 US: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.1.6.2.4 US: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.1.6.2.4.1 US: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.6.2.5 US: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.1.6.3 Canada
11.1.6.3.1 Canada dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.6.3.2 Canada: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.1.6.3.3 Canada: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.1.6.3.4 Canada: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.1.6.3.4.1 Canada: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.6.3.5 Canada: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.1.6.4 Mexico
11.1.6.4.1 Mexico dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.6.4.2 Mexico: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.1.6.4.3 Mexico: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.1.6.4.4 Mexico: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.1.6.4.4.1 Mexico: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.6.4.5 Mexico: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2 Europe dPCR and qPCR Market, Revenue and Forecast to 2030
11.2.1 Overview
11.2.2 Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.3 Europe: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.4 Europe: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.5 Europe: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.5.1 Europe: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.2.6 Europe: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.1 Europe dPCR and qPCR Market, by Country
11.2.6.2 UK
11.2.6.2.1 UK dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.2.2 UK: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.2.3 UK: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.2.4 UK: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.2.4.1 UK: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.2.6.2.5 UK: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.3 Germany
11.2.6.3.1 Germany dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.3.2 Germany: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.3.3 Germany: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.3.4 Germany: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.3.4.1 Germany: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.2.6.3.5 Germany: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.4 France
11.2.6.4.1 France dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.4.2 France: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.4.3 France: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.4.4 France: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.4.4.1 France: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.2.6.4.5 France: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.5 Italy
11.2.6.5.1 Italy dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.5.2 Italy: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.5.3 Italy: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.5.4 Italy: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.5.4.1 Italy: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.2.6.5.5 Italy: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.6 Spain
11.2.6.6.1 Spain dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.6.2 Spain: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.6.3 Spain: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.6.4 Spain: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.6.4.1 Spain: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.2.6.6.5 Spain: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.7 Rest of Europe
11.2.6.7.1 Rest of Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.7.2 Rest of Europe: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.7.3 Rest of Europe: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.7.4 Rest of Europe: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.7.4.1 Rest of Europe: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.2.6.7.5 Rest of Europe: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3 Asia Pacific dPCR and qPCR Market, Revenue and Forecast to 2030
11.3.1 Overview
11.3.2 Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3 Asia Pacific: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.4 Asia Pacific: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.5 Asia Pacific: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.5.1 Asia Pacific: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.3.6 Asia Pacific: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.1 Asia Pacific dPCR and qPCR Market, by Country
11.3.6.2 China
11.3.6.2.1 China dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.2.2 China: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.2.3 China: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.2.4 China: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.2.4.1 China: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.3.6.2.5 China: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.3 Japan
11.3.6.3.1 Japan dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.3.2 Japan: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.3.3 Japan: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.3.4 Japan: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.3.4.1 Japan: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.3.6.3.5 Japan: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.4 India
11.3.6.4.1 India dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.4.2 India: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.4.3 India: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.4.4 India: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.4.4.1 India: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.3.6.4.5 India: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.5 Australia
11.3.6.5.1 Australia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.5.2 Australia: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.5.3 Australia: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.5.4 Australia: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.5.4.1 Australia: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.3.6.5.5 Australia: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.6 South Korea
11.3.6.6.1 South Korea dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.6.2 South Korea: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.6.3 South Korea: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.6.4 South Korea: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.6.4.1 South Korea: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.3.6.6.5 South Korea: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.7 Rest of Asia Pacific
11.3.6.7.1 Rest of Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.7.2 Rest of Asia Pacific: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.7.3 Rest of Asia Pacific: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.7.4 Rest of Asia Pacific: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.7.4.1 Rest of Asia Pacific: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.3.6.7.5 Rest of Asia Pacific: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.4 Middle East & Africa dPCR and qPCR Market, Revenue and Forecast to 2030
11.4.1 Overview
11.4.2 Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.4.4 Middle East & Africa: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.4.5 Middle East & Africa: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.4.5.1 Middle East & Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.4.6 Middle East & Africa: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.4.6.1 Middle East & Africa dPCR and qPCR Market, by Country
11.4.6.2 Saudi Arabia
11.4.6.2.1 Saudi Arabia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.2.2 Saudi Arabia: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.4.6.2.3 Saudi Arabia: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.4.6.2.4 Saudi Arabia: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.4.6.2.4.1 Saudi Arabia: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.4.6.2.5 Saudi Arabia: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.4.6.3 UAE
11.4.6.3.1 UAE dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.3.2 UAE: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.4.6.3.3 UAE: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.4.6.3.4 UAE: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.4.6.3.4.1 UAE: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.4.6.3.5 UAE: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.4.6.4 South Africa
11.4.6.4.1 South Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.4.2 South Africa: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.4.6.4.3 South Africa: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.4.6.4.4 South Africa: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.4.6.4.4.1 South Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.4.6.4.5 South Africa: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.4.6.5 Rest of Middle East & Africa
11.4.6.5.1 Rest of Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.5.2 Rest of Middle East & Africa: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.4.6.5.3 Rest of Middle East & Africa: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.4.6.5.4 Rest of Middle East & Africa: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.4.6.5.4.1 Rest of Middle East & Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.4.6.5.5 Rest of Middle East & Africa: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.5 South & Central America dPCR and qPCR Market, Revenue and Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3 South & Central America: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.5.4 South & Central America: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.5.5 South & Central America: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.5.5.1 South & Central America: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.5.6 South & Central America: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.5.6.1 South & Central America dPCR and qPCR Market, by Country
11.5.6.2 Brazil
11.5.6.2.1 Brazil dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.2.2 Brazil: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.5.6.2.3 Brazil: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.5.6.2.4 Brazil: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.5.6.2.4.1 Brazil: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.5.6.2.5 Brazil: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.5.6.3 Argentina
11.5.6.3.1 Argentina dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.3.2 Argentina: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.5.6.3.3 Argentina: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.5.6.3.4 Argentina: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.5.6.3.4.1 Argentina: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.5.6.3.5 Argentina: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.5.6.4 Rest of South & Central America
11.5.6.4.1 Rest of South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.4.2 Rest of South & Central America: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.5.6.4.3 Rest of South & Central America: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.5.6.4.4 Rest of South & Central America: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.5.6.4.4.1 Rest of South & Central America: dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.5.6.4.5 Rest of South & Central America: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
12. dPCR and qPCR Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in dPCR and qPCR Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takara Bio Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Qiagen NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Standard BioTools Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Lepu Medical Technology Beijing Co Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 F. Hoffmann-La Roche Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Bio-Rad Laboratories Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Agilent Technologies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Genome Diagnostics Pvt Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 SWOT Analysis
13.10.5 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

LIST OF TABLES

Table 1. dPCR and qPCR Market Segmentation
Table 2. dPCR and qPCR Market, by Clinical Application – Revenue and Forecast to 2030 (US$ Million)
Table 3. North America dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 5. North America dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. North America dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. North America dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 8. US dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 9. US dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 10. US dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 11. US dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12. US dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 13. Canada dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 14. Canada dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. Canada dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16. Canada dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. Canada dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Mexico dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 19. Mexico dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 20. Mexico dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 21. Mexico dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 22. Mexico dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 23. Europe dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 24. Europe dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 25. Europe dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 26. Europe dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 27. Europe dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 28. UK dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 29. UK dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 30. UK dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 31. UK dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 32. UK dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 33. Germany dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 34. Germany dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 35. Germany dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 36. Germany dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 37. Germany dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 38. France dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 39. France dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 40. France dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 41. France dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 42. France dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 43. Italy dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 44. Italy dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 45. Italy dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 46. Italy dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 47. Italy dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 48. Spain dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 49. Spain dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 50. Spain dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 51. Spain dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 52. Spain dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 53. Rest of Europe dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 54. Rest of Europe dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 55. Rest of Europe dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 56. Rest of Europe dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 57. Rest of Europe dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 58. Asia Pacific dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 59. Asia Pacific dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 60. Asia Pacific dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 61. Asia Pacific dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 62. Asia Pacific dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 63. China dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 64. China dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 65. China dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 66. China dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 67. China dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 68. Japan dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 69. Japan dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 70. Japan dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 71. Japan dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 72. Japan dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 73. India dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 74. India dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 75. India dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 76. India dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 77. India dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 78. Australia dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 79. Australia dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 80. Australia dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 81. Australia dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 82. Australia dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 83. South Korea dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 84. South Korea dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 85. South Korea dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 86. South Korea dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 87. South Korea dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 88. Rest of Asia Pacific dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 89. Rest of Asia Pacific dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 90. Rest of Asia Pacific dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 91. Rest of Asia Pacific dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 92. Rest of Asia Pacific dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 93. Middle East & Africa dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 94. Middle East & Africa dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 95. Middle East & Africa dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 96. Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 97. Middle East & Africa dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 98. Saudi Arabia dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 99. Saudi Arabia dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 100. Saudi Arabia dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 101. Saudi Arabia dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 102. Saudi Arabia dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 103. UAE dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 104. UAE dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 105. UAE dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 106. UAE dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 107. UAE dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 108. South Africa dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 109. South Africa dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 110. South Africa dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 111. South Africa dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 112. South Africa dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 113. Rest of Middle East & Africa dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 114. Rest of Middle East & Africa dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 115. Rest of Middle East & Africa dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 116. Rest of Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 117. Rest of Middle East & Africa dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 118. South & Central America dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 119. South & Central America dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 120. South & Central America dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 121. South & Central America dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 122. South & Central America dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 123. Brazil dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 124. Brazil dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 125. Brazil dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 126. Brazil dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 127. Brazil dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 128. Argentina dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 129. Argentina dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 130. Argentina dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 131. Argentina dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 132. Argentina dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 133. Rest of South & Central America dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 134. Rest of South & Central America dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 135. Rest of South & Central America dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 136. Rest of South & Central America dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 137. Rest of South & Central America dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 138. Recent Organic Growth Strategies in dPCR and qPCR Market
Table 139. Recent Inorganic Growth Strategies in the dPCR and qPCR Market
Table 140. Glossary of Terms, dPCR and qPCR Market

LIST OF FIGURES

Figure 1. dPCR and qPCR Market Segmentation, By Geography
Figure 2. Global – PEST Analysis
Figure 3. dPCR and qPCR Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. dPCR and qPCR Market Revenue (US$ Mn), 2022 – 2030
Figure 6. dPCR and qPCR Market Revenue, Geography (US$ Mn), 2022 – 2030
Figure 7. dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
Figure 8. Quantitative PCR: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Digital PCR: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
Figure 11. Reagents & Consumables: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Instruments: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Software & Services: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 15. Research Application: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Clinical Application: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Forensic Application: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
Figure 19. Hospitals and Diagnostic Centers: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Pharmaceutical and Biotechnology Companies: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Research Laboratories and Academic Institutes: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Forensic Laboratories: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Clinical Research Organizations: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America: dPCR and qPCR Market, by Key Country – Revenue (2022) (US$ Million)
Figure 25. North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. North America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
Figure 27. US dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Canada dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Mexico dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Europe dPCR and qPCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 31. Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Europe dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
Figure 33. UK dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Germany dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. France dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Italy dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Spain dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Rest of Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Asia Pacific dPCR and qPCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 40. Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Asia Pacific dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
Figure 42. China dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Japan dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 44. India dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. Australia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 46. South Korea dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. Rest of Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 48. Middle East & Africa dPCR and qPCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 49. Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. Middle East & Africa dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
Figure 51. Saudi Arabia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. UAE dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 53. South Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. Rest of Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. South & Central America dPCR and qPCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 56. South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. South & Central America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
Figure 58. Brazil dCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. Argentina dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 60. Rest of South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. Growth Strategies in dPCR and qPCR Market

The List of Companies – dPCR and qPCR Market
o Abbott Laboratories
o Thermo Fisher Scientific Inc.
o Takara Bio Inc.
o Qiagen NV
o Standard Biotools Inc.
o Lepu Medical Technology Beijing Co Ltd
o F. Hoffmann-la Roche Ltd
o Bio-rad Laboratories Inc
o Agilent Technologies Inc
o Genome Diagnostics Pvt Ltd.

Reviews

There are no reviews yet.

Be the first to review “dPCR and qPCR Market Size and Forecasts (2020-2030)”